Hypercoagulability in critically ill patients with COVID 19, an observational prospective study
Open Access
- 23 November 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (11) , e0277544
Abstract
COVID 19 is often associated with hypercoagulability and thromboembolic (TE) events. The aim of this study was to assess the characteristics of hypercoagulability and its relationship with new-onset TE events and the composite outcome of need for intubation and/or death in intensive care unit (ICU) patients admitted for COVID. Prospective observational study. Monocentric, intensive care, University Hospital of Clermont Ferrand, France. Patients admitted to intensive care from January 2020 to May 2021 for COVID-19 pneumonia. Standard hemostatic tests and rotational thromboelastometry (ROTEM) were performed on admission and on day 4. Hypercoagulability was defined by at least one of the following criteria: D-dimers > 3000 μg/dL, fibrinogen > 8 g/L, EXTEM CFT below the normal range, EXTEM A5, MCF, Li 60 above the normal range, and EXTEM G-score ((5000 x MCF) / (100-MCF)) ≥ 11 dyne/cm2. Of the 133 patients included, 17 (12.7%) developed new-onset TE events, and 59 (44.3%) required intubation and/or died in the ICU. ROTEM was performed in 133 patients on day 1 and in 67 on day 4. Hypercoagulability was present on day 1 in 115 (86.4%) patients. None of the hypercoagulability indices were associated with subsequent new-onset TE events on days 1 and 4 nor with the need for intubation and/or ICU death. Hyperfibrinogenemia > 8g/dL, higher D-dimers and higher EXTEM Li 60 on day 4 were predictive of need for intubation and/or of ICU death. Our study confirmed that most COVID-19 ICU patients have hypercoagulability on admission and almost all on day 4. Hyperfibrinogenemia or fibrinolysis shutdown on day 4 were associated with unfavorable outcome.Keywords
Funding Information
- Michelin Corporate Foundation
This publication has 66 references indexed in Scilit:
- Perioperative Thromboelastometry for Adult Living Donor Liver Transplant Recipients with a Tendency to Hypercoagulability: A Prospective Observational Cohort StudyTransfusion Medicine and Hemotherapy, 2018
- The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital‐associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2018
- Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinomaDigestive and Liver Disease, 2017
- Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2016
- Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgeryCritical Care, 2014
- Monitoring of treatment with low molecular weight heparins using viscoelastic devicesCritical Care, 2014
- Pre-existing hypercoagulability in patients undergoing potentially curative cancer resectionSurgery, 2014
- Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgerySurgical Endoscopy, 2013
- Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagentBlood Coagulation & Fibrinolysis, 2010
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005